How to Build a Scientifically Justified AET for Extractables and Leachables (E&L) Studies
Introduction: Why AET Derivation Is the Defining Step in E&L Studies The Analytical Evaluation Threshold (AET) is the single most […]
Peptide Biosimilar Characterization Using LC-MS: Challenges and Analytical Solutions
Introduction: Why Peptide Biosimilar Characterization Using LC-MS Requires More Than Conventional Proteomics Peptide biosimilar characterization using LC-MS is far more
Peptide Biosimilar Characterization Using LC-MS: Challenges and Analytical Solutions Read More »
In Silico Potency Prediction for NDSRIs: Using SAR, DEREK, and CASE Ultra for Hazard Classification
Introduction: Why Conventional Mutagenicity Models Are Inadequate for NDSRIs The regulatory complexity associated with N-Nitrosamine Drug Substance-Related Impurities (NDSRIs) extends
Anti-Drug Antibody (ADA) Assay Development and Validation Services for Biologic Therapies
Introduction: Anti-Drug Antibody (ADA) Assay Development Services play a critical role in evaluating the immunogenicity of biologic therapies. As biologics
Regulated Bioanalytical Services for NDA and BLA Submissions: What to Look for in a CRO
Introduction: Why CRO Selection Is a Regulatory Decision, Not Just a Scientific One When sponsors prepare regulated bioanalytical services for
Regulated Bioanalytical Services for NDA and BLA Submissions: What to Look for in a CRO Read More »
How to Investigate Unknown Peaks in Extractables & Leachables Study
Introduction: The Most Overlooked Challenge in E&L Science Unknown Peak Identification in Extractables and Leachables (E&L) testing is among the
How to Investigate Unknown Peaks in Extractables & Leachables Study Read More »
Extractables and Leachables from Elastomeric Closures: Regulatory Expectations
Introduction: Extractables and Leachables from Elastomeric Closures are a major focus area in pharmaceutical packaging and regulatory compliance because elastomeric
Extractables and Leachables from Elastomeric Closures: Regulatory Expectations Read More »
Top-Down vs Bottom-Up Proteomics for Biosimilars: Which Approach is Better?
Introduction: The Analytical Choice That Shapes Biosimilar Comparability In biosimilar development, selecting the appropriate proteomics strategy is far more than
Top-Down vs Bottom-Up Proteomics for Biosimilars: Which Approach is Better? Read More »
GLP-1 Biosimilars: Mass Spectrometry Challenges in Semaglutide and Exenatide Characterization
Introduction: The rapid expansion of GLP-1 receptor agonist therapeutics has increased the need for robust GLP-1 Biosimilar Characterization strategies. Peptide
Solvent Medium Selection in Extractables Studies and Why They Matter
Introduction: Why Solvent Selection in Extractables Studies Is a Regulatory Science Decision One of the most overlooked variables in extractables
Solvent Medium Selection in Extractables Studies and Why They Matter Read More »